Real-time enrollment status for this myelodysplastic syndrome clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:52 AM UTC
| NCT Number | NCT06577441 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 54 participants |
| Active Locations | 145 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 15, 2026: Clinical trial NCT06577441 is currently recruiting participants. This phase2 study for myelodysplastic syndrome is actively seeking new participants at 145 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06577441 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 145 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06577441 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.